OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 301.1

Change

-1.90 (-0.63)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-1.25 (-2.39%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-1.48 (-2.56%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.39 (-2.49%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.48B
0ZC:F Zscaler Inc

-3.58 (-1.84%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.74%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.86% 46% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.86% 45% F 50% F
Trailing 12 Months  
Capital Gain 10.03% 68% D+ 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.03% 65% D 54% F
Trailing 5 Years  
Capital Gain 75.81% 59% D- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 75.81% 59% D- 43% F
Average Annual (5 Year Horizon)  
Capital Gain 9.61% 66% D+ 63% D
Dividend Return 9.61% 64% D 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.83% 68% D+ 91% A-
Risk Adjusted Return 97.76% 88% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike